Archives: Agenda

• Navigate new regulatory requirements and complex study designs with larger sample sizes and a broader global footprint
• Implement country and site selection strategies that optimize FPI/LPI milestones
• Manage the complexities of enrollment, cohort management, safety review, and trial logistics across multiple regions
• Maintain a patient-centric approach to optimize study coordination and to benefit patienta

• Designing a protocol that adapts to increased complexities in trials to shorten timelines
• Creating adaptable designs that allows flexibility during trials for increased efficiency
• Strengthening foundations of your trial with a clearly defined protocol ensuring the collection of valid data

• Patient identification: how to find patients who are eligible to participate in trials for rare forms of cancer
• Collaborating with patient advocacy groups to facilitate and boost recruitment
• What makes recruiting for a rare cancer trial unique?

There is an urgency to speed up clinical trial processes. To identify and eliminate operational inefficiencies that cause bottlenecks. To ensure concerted efforts from investigators and study teams, sponsors, and other key operational partners combine to conserve resources and time, and, most importantly, accelerate progress in cancer research.

This presentation explores just how to do so with key insights that look at how to attain:

• Data-driven Selection to Choose a Region for Your Trial Expansion
• Risk Response Strategies and a Mitigation Framework
• Clear Communication and a Culture of Accountability Among Partners
• Case Studies on Canada as a Trial Expansion Region

• Exploring communication methods that encourage a collaborative culture across a company
• Implementing a strategy that breaks down silos and redefines how teams work together
• How working closely with other teams can foster collaboration when working towards shared goals

• Review the challenges of long-term patient engagement and why ongoing communication is crucial
• Explore the role of virtual call centers in bridging patients and research teams
• Understand how virtual centers can alleviate burden on clinical sites and streamline patient management
• Highlight the impact on patient retention, data quality, and timely adverse event reporting

• Evaluating regulation and the impact on oncology clinical
• Navigating the evolving regulatory landscape effectively
• Understanding how the geopolitical landscape is affecting oncology trials inside and outside of the US

• Analyzing the latest trends in technology that assist in delivering a better patient experience
• Utilizing technologies that enhance patient experience and efficiency of study
• Understanding how to successfully incorporate new technology to improve patient trial experience